Accelerating Discovery of Liver Disease Mechanisms

Google DeepMind describes how Filippo Menolascina is using Co-Scientist to investigate liver disease, identify potential new treatments, and explain why existing drugs benefit only certain patients. The supplied abstract frames the system as a tool for generating and examining mechanistic hypotheses. It does not specify the liver disease subtype, candidate drugs, experimental sample sizes, quantitative results, or clinical validation. The report should therefore be read as an early research-workflow case study, not as evidence that a new treatment has been proven effective.